Page last updated: 2024-08-22

camptothecin and molybdenum

camptothecin has been researched along with molybdenum in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brewer, GJ; Gartner, EM; Griffith, KA; Henja, GF; Merajver, SD; Pan, Q; Zalupski, MM	1
Cheng, L; Feng, L; Gong, H; Gu, X; Liu, T; Liu, Z; Shi, X; Sun, B; Wang, C	1
Jia, L; Li, B; Li, F; Liu, J; Zhang, D; Zheng, J	1

Trials

1 trial(s) available for camptothecin and molybdenum

Article	Year
A pilot trial of the anti-angiogenic copper lowering agent tetrathiomolybdate in combination with irinotecan, 5-flurouracil, and leucovorin for metastatic colorectal cancer. Investigational new drugs, 2009, Volume: 27, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chelating Agents; Colorectal Neoplasms; Copper; Cytokines; Disease-Free Survival; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Molybdenum; Neoplasm Metastasis; Pilot Projects	2009

Article

Year

A pilot trial of the anti-angiogenic copper lowering agent tetrathiomolybdate in combination with irinotecan, 5-flurouracil, and leucovorin for metastatic colorectal cancer.

Investigational new drugs, 2009, Volume: 27, Issue:2

Topics: Adenocarcinoma; Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chelating Agents; Colorectal Neoplasms; Copper; Cytokines; Disease-Free Survival; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Molybdenum; Neoplasm Metastasis; Pilot Projects

2009

Other Studies

2 other study(ies) available for camptothecin and molybdenum

Article	Year
Drug delivery with PEGylated MoS2 nano-sheets for combined photothermal and chemotherapy of cancer. Advanced materials (Deerfield Beach, Fla.), 2014, Jun-04, Volume: 26, Issue:21 Topics: Animals; Antineoplastic Agents; Camptothecin; Cell Line, Tumor; Cell Survival; Chlorophyllides; Combined Modality Therapy; Disulfides; Doxorubicin; Drug Carriers; Female; HeLa Cells; Humans; Irinotecan; KB Cells; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Molybdenum; Nanostructures; Phototherapy; Pilot Projects; Polyethylene Glycols; Porphyrins; Radiation-Sensitizing Agents	2014
Redox/NIR dual-responsive MoS Journal of nanobiotechnology, 2019, Jul-03, Volume: 17, Issue:1 Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line, Tumor; Cell Survival; Combined Modality Therapy; Disulfides; Drug Carriers; Drug Liberation; Female; Fluorescent Dyes; Humans; Hyaluronic Acid; Hyperthermia, Induced; Infrared Rays; Mice, Nude; Molybdenum; Nanoparticles; Neoplasm Transplantation; Neoplasms; Oxidation-Reduction; Photochemotherapy	2019

Article

Year

Drug delivery with PEGylated MoS2 nano-sheets for combined photothermal and chemotherapy of cancer.

Advanced materials (Deerfield Beach, Fla.), 2014, Jun-04, Volume: 26, Issue:21

Topics: Animals; Antineoplastic Agents; Camptothecin; Cell Line, Tumor; Cell Survival; Chlorophyllides; Combined Modality Therapy; Disulfides; Doxorubicin; Drug Carriers; Female; HeLa Cells; Humans; Irinotecan; KB Cells; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Molybdenum; Nanostructures; Phototherapy; Pilot Projects; Polyethylene Glycols; Porphyrins; Radiation-Sensitizing Agents

2014

Redox/NIR dual-responsive MoS

Journal of nanobiotechnology, 2019, Jul-03, Volume: 17, Issue:1

Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line, Tumor; Cell Survival; Combined Modality Therapy; Disulfides; Drug Carriers; Drug Liberation; Female; Fluorescent Dyes; Humans; Hyaluronic Acid; Hyperthermia, Induced; Infrared Rays; Mice, Nude; Molybdenum; Nanoparticles; Neoplasm Transplantation; Neoplasms; Oxidation-Reduction; Photochemotherapy

2019